Jane Street’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20,500
Closed -$490K 10854
2021
Q1
$490K Buy
+20,500
New +$381K ﹤0.01% 6841
2020
Q4
Sell
-45,200
Closed -$642K 8434
2020
Q3
$642K Buy
+45,200
New +$691K ﹤0.01% 4778

Jane Street's GNMK Position: Q2 2021 in Review

Jane Street sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 57,610 shares — an estimated $1.38M sold.

Jane Street first reported a position in GNMK in Q4 2013 and held it in 6 quarters. The position peaked at $1.38M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Jane Street reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Jane Street sold 57,610 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.38M.
  • Jane Street first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 6 quarters.
  • Jane Street's GenMark Diagnostics, Inc position peaked at $1.38M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.